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resistant to clindamycin. The most prevalent serotypes were
serotypes 19F (20%), 23F(15, 7%) and 18C (12, 6%) among
isolates from the 1 group and 6B(18,4%), 9B (16, 9%) and
14 (27, 6%) among isolates of the 2nd group. On performing
PFGE there were revealed more diversity in strains of the
1st group then in strains gained in the 2nd group of patients
with low immune status (17 genotypes vs. 6 genotypes).
Conclusion: The morbidity on pneumococcal pneumonia
is still remaining underestimated problem in our area and
requires careful epidemiology surveillance. There is ten-
dency to forming of epidemic clone which could play role
in appearance of nosocomial pneumococcal infections in
patietns with hematology diseases.
doi:10.1016/j.ijid.2008.05.692
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Background: Methicillin-Resistant Staphylococcus aureus
(MRSA) is a serious cause of nosocomial infection in Malaysia.
Sixty-six MRSA isolates recovered from patients from Uni-
versiti Malaya Medical Centre, KL over a 4-year period
(2003—2007) were studied to determine the clonal relation-
ship of sporadic (year 2004 and 2007) and outbreak (year
2003) isolates.
Methods: Polymerase chain reaction was carried out on
the isolates to detect the mecA gene which is primarily
responsible for the methicillin resistance in Staphylococcus
aureus. Pulsed-ﬁeld gel electrophoresis (PFGE) of SmaI-
digested chromosomal DNA and antimicrobial susceptibility
tests were carried out.
Results: Antimicrobial susceptibility tests generated 34
antibiograms with 100% of isolates being susceptible to
vancomycin. Majority of the isolates showed susceptibility
towards fusidic acid (91%), clindamycin (82%), vancomycin
(100%) and rifampin (89%), indicating that these antibiotics
will be/are effective in treating MRSA infections. A dendro-
gram based on the clustering of the antibiograms showed
two major clusters (AM1 and AM2), with AM 2 being primar-
ily sporadic isolates. The majority of outbreak isolates were
represented by 3 distinct antibiograms that clustered in
AM1. Isolates susceptible to gentamicin, sulfamethoxazole-
trimethoprim(SXT) and tetracycline gave distinctly differ-
ent PFGE proﬁles, and were clustered together. Chi-square
or Fishers exact test showed that there was a signiﬁcant
difference (p < 0.05) in antimicrobial resistant between spo-
radic and outbreak isolates for amikacin, SXT, tetracycline
and gentamicin.
Fifty-nine isolates (89%) were mecA positive and showed
the presence of the 533bp amplicon, while 7 isolates (11%)
were mecA negative. These 7 isolates however showed
phenotypic resistance to methicillin. Genotyping by PFGE
showed 55 proﬁles, consisting of 13—17 bands. Among the
25 outbreak isolates, 22 PFGE proﬁles were obtained, sug-
gesting that the outbreak did not originate from a single
point source. Majority (93%) of isolates from year 2007 were
clustered together. The diverse PFGE proﬁles obtained from
the sporadic isolates indicated that MRSA were genetically
diverse, and the diversity may be explained by the patients
coming from different hospital wards.
Conclusion: The clonal relationship of outbreak and spo-
radic isolates and their antimicrobial susceptibility were
determined. These ﬁndings aid in hospital infection control,
lower the mortality rate of patients and reduce monetary
loss to the hospital. The reemergence of isolates suscep-
tible to amikacin- gentamicin-SXT-tetracycline may denote
presence of MRSA in the community where such antibiotic
exposure is minimal.
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Although macrolides, including erythromycin A (EMA),
have been widely prescribed for more than 50 years, the
emergence of widespread bacterial resistance is a seri-
ous and expanding problem. There is a great medical
need for new macrolide antibiotics to speciﬁcally cope
with the problems of antibiotic resistance, especially to
combat methicillin-resistant Staphylococcus aureus (MRSA)
and vancomycin-resistant Enterococcus (VRE) strains of
bacteria. We have now re-examined various derivatives
of EMA, previously synthesized at The Kitasato Insti-
tute, evaluating them against 12 types of Gram-positive
bacteria, including macrolide-resistant strains, and one
Gram-negative organism. We found that 11,12-di-O-butyryl-
8,9-anhydroerythromycin A 6,9-hemiketal (EM413) showed
moderate minimum inhibitory concentration (MIC) against
four types of MRSA strains and two types of VRE strains.
We subsequently investigated several 11,12-di-O-acyl-8,9-
anhydroerythromycin A 6,9-hemiketal derivatives to eluci-
date their structure-activity relationships against anti-MRSA
and VRE bacteria. After screening various diacyl com-
pounds, 11,12-di-O-isobutyryl-8,9-anhydroerythromycin A
6,9-hemiketal (EM1015) was found to be active against MRSA
and VRE strains. Furthermore, to obtain higher potency
compounds, we synthesized new 8,9-anhydroerythromycin
A 6,9-hemiketal derivatives using a copper catalyzed azide-
alkyne cyclization reaction (‘click chemistry’). Using click
chemistry, we replaced the cladinose moiety on the C3
hydroxy with a -CH2-CCH group, to enable a fast SAR. This
was done because the cladinose of EMA is not essential for
its antibacterial activity, plus this moiety induces macrolide-
drug-resistance. We then discovered that the propargyl and
some triazole groups can be substituted, instead of cladi-
nose, to produce better anti-MRSA and anti-VRE activity.
One of 10 kinds of triazole compounds, the adamantyl tri-
azole product (EM1035), was generated as a potentially
